Press Releases
UNIONDALE, NY, Aug 15, 2024 — The Lustgarten Foundation, the nation’s largest private funder of pancreatic cancer research, today announced a landmark year of funding, awarding ten new grants to […]
CAI grants awarded to Eric Christenson, MD, & Andrew Lowy, MD WOODBURY, N.Y., July 30, 2024 — The Lustgarten Foundation has announced two new Dr. Robert F. Vizza Lustgarten Clinical […]
Richard Barakat, MD, and Aaron Kantoff join the Lustgarten Foundation Board of Directors Woodbury, New York, June 11, 2024 – The Lustgarten Foundation, the largest private funder of pancreatic cancer […]
Fiyinfolu Balogun, MD, PhD, Assistant Professor, Memorial Sloan Kettering Cancer Center, Awarded 2024 LEAD Project Grant WOODBURY, N.Y., May 30, 2024 — The Lustgarten Foundation has announced that the 2024 […]
Linda Resar, MD, Professor of Medicine, Oncology, and Pathology, Johns Hopkins University, Awarded 2024 Innovation and Collaboration Program Grant WOODBURY, N.Y., May 27, 2024 — The Lustgarten Foundation announced today […]
The remarkable gift will support the LABS (Lustgarten Advancing Breakthrough Science) Program. WOODBURY, N.Y., May 1, 2024 — The Lustgarten Foundation today announced a remarkable $500,000 donation from The Warren […]
Over 300 pancreatic cancer supporters united at Hudson River Park’s Pier 84 in New York City New York, N.Y., Apr 22, 2024 — Over 300 pancreatic cancer supporters united at […]
With thanks and appreciation to our contributing partner, Let’s Win Pancreatic Cancer. The U.S. Food and Drug Administration has approved irinotecan liposome (ONIVYDE) in combination with oxaliplatin, fluorouracil, and leucovorin, […]